Dengue care: who needs hospital or transfusion?
Part of Blood & lymphatic, Infections clinical trials.
This study looks at why some people with dengue need to be hospitalized or get a blood transfusion. It aims to make care safer and help doctors know who needs closer monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 5 years old.
- You must have dengue confirmed by a lab test (like NS1, IgM, or PCR).
- This must be your first visit for dengue symptoms — to an emergency room or outpatient clinic.
- You cannot have COVID-19 or another mosquito-borne virus at the same time.
- You cannot have a blood disorder or cancer (past or present).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new medicines for people hospitalized with moderate-to-severe dengue fever. Dengue is a mosquito-borne virus that can cause serious complications like severe bleeding, organ damage, or shock. The trial aims to find treatments that help patients recover faster and avoid life-threatening complications.
This study creates a registry to track how dengue infection affects people with congenital bleeding disorders, such as hemophilia. It aims to learn more about managing dengue in this group.
This study looks at how the immune system responds to dengue fever and sepsis (a severe infection). It aims to better understand these illnesses, which could lead to improved treatments. If you have dengue-like symptoms, sepsis, or are a healthy volunteer, you may be able to join.
This Phase 2 study tests whether zanamivir given through a vein can improve outcomes in people with dengue infection who have warning signs. It may help by reducing the body problems dengue can cause in blood vessels and fluid balance.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This trial tests whether a medicine called emetine can help adults hospitalized with dengue. If you have a confirmed dengue infection and symptoms like fever, headache, or body aches, this study may be for you.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.